← HHS Federal Register rules

Medical Devices; Immunology and Microbiology Devices; Classification of the Zika Virus Serological Reagents

fda-device · Food and Drug Administration · Rule · Published 2025-05-29 · Effective 2025-05-29 · 90 FR 22632

Document

Document number
2025-09639
Federal Register citation
90 FR 22632
CFR reference
21 CFR 866
Type
Rule
Action
Final amendment; final order.
Category
fda-device
Sub-agency
Food and Drug Administration
Publication date
2025-05-29
Effective date
2025-05-29
HHS docket
Docket No. FDA-2025-N-1160

Abstract

The Food and Drug Administration (FDA, Agency, or we) is classifying the Zika virus serological reagents into class II (special controls). The special controls that apply to the device type are identified in this order and will be part of the codified language for the Zika virus serological reagents' classification. We are taking this action because we have determined that classifying the device into class II (special controls) will provide a reasonable assurance of safety and effectiveness of the device. We believe this action will also enhance patients' access to beneficial innovative devices in part by reducing regulatory burdens.

Source

Authoritative
Federal Register document
Machine
JSON-LD · Markdown